Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer.
about
Hormonal-receptor positive breast cancer: IL-6 augments invasion and lymph node metastasis via stimulating cathepsin B expressionInterleukin-6 as a biomarker for asthma: hype or is there something else?Small GTPase RBJ promotes cancer progression by mobilizing MDSCs via IL-6.Altered Toll-like receptor expression and function in HPV-associated oropharyngeal carcinoma.The Androgen Receptor Supports Tumor Progression After the Loss of Ovarian Function in a Preclinical Model of Obesity and Breast Cancer.
P2860
Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Interleukin-6 is a potential t ...... ptor-α-positive breast cancer.
@ast
Interleukin-6 is a potential t ...... ptor-α-positive breast cancer.
@en
type
label
Interleukin-6 is a potential t ...... ptor-α-positive breast cancer.
@ast
Interleukin-6 is a potential t ...... ptor-α-positive breast cancer.
@en
prefLabel
Interleukin-6 is a potential t ...... ptor-α-positive breast cancer.
@ast
Interleukin-6 is a potential t ...... ptor-α-positive breast cancer.
@en
P2093
P2860
P356
P1476
Interleukin-6 is a potential t ...... ptor-α-positive breast cancer.
@en
P2093
A Kate Sasser
Amy E Axel
Brett M Hall
Jillian L Werbeck
John D Alvarez
Karin Verstraeten
Peter King
Tineke Casneuf
Tinne Verhulst
P2860
P356
10.2147/BCTT.S92414
P577
2016-02-03T00:00:00Z